All Perspectives

8291 total results. Page 197 of 332.

Why be competitors, when friends can get it done?
In many mass tort cases, and particularly in cases involving exposure to a substance with a long latency period, defendants and plaintiffs must rely on documents created decades ago.
If the turbulence of 2018 caused business executives grief, the year ahead is unlikely to provide much relief.  Foremost is the United States-Mexico-Canada Agreement (USMCA). If most political pundits are correct, the three governments will likely be able to ratify the USMCA in time to be in full fo
VW is looking for their autonomous BFF.
After stepping up as one of the first law firms to sign the ABA mental health pledge, these expanded offerings advance the firm’s ongoing wellness initiative.
The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or biological covered by Medicare or Medicaid to include a disclosure of the product’s “current list price” for a “typical” thirty day supply.
On October 11, the United States Patent and Trademark Office published a new final rule altering the claim construction standard applied in inter partes review, post grant review, and covered business method review proceedings.
The next time you’re on Ben Yehuda Street you might just hail an autonomous taxi.
In a key decision earlier this month with potentially hefty ongoing implications for developers and property owners, the U.S. Court of Appeals for the Third Circuit held a chemical company liable for nearly $1 million in pre-acquisition cleanup costs.
Partner Andrew Sawula, co-founder and leader of the firm’s Disability Inclusion Group, explained how making disability accommodations available to all attorneys helps combat the stigma associated with having a physical or mental health disability.
A German court in Stuttgart has ordered Porsche SE to pay its investors for failing to provide timely information about the Volkswagen diesel emissions scandal.
On October 17, 2018, Canada celebrated Legalization Day – an event marking the end of a prohibition against recreational cannabis use. 
Don’t waive the checkered flag yet in autonomous race in San Francisco.
Schiff successfully secured complete relief from deportation to Iraq for a pro bono client who was detained for over 13 months by U.S. Immigration and Customs Enforcement (ICE).
On Friday, October 19, 2018, the Maryland Attorney General (AG) filed a petition for writ of certiorari to the United States Supreme Court (SCOTUS) regarding Maryland’s drug price gouging law (the Law)– the first state law enacted to prohibit alleged drug price gouging by manufacturers.
Schiff successfully secured an evidentiary hearing on a post-conviction petition filed on behalf of our pro bono client, who was convicted of first-degree murder in 2014 and sentenced to a 55-year imprisonment.
Schiff Hardin LLP has been recognized on the BTI Litigation Outlook 2019 Honor Roll in three separate areas of litigation, including Complex Employment Litigation and Complex Commercial Litigation.
Much has been written about the problem of the stagnating electricity market due to a combination of falling demand, widespread energy efficiency initiatives, lower electricity costs, and aging infrastructure.
Long-anticipated changes to California’s Proposition 65 warning requirements took effect on August 30, 2018, through amendments and new rules issued by the California Office of Environmental Health Hazard Assessment.
Long-anticipated changes to California’s Proposition 65 warning requirements took effect on August 30, 2018, through amendments and new rules issued by the California Office of Environmental Health Hazard Assessment.
Efforts to update FDA’s personal care products regulations continue as Rep. Jan Schakowsky (D-IL) recently introduced H.R. 6903, the “Safe Cosmetics and Personal Care Products Act of 2018.” 
President Trump is expected to sign into law a bill which will – among other things – expand the scope of the Open Payments reporting requirements mandated by Section 6002 of the Patient Protection and Affordable Care Act (often referred to as the Sunshine Act).